If someone experiences severe side effects, such as chest pain, difficulty breathing, or thoughts of self-harm, it is important to seek medical help immediately
16 Because the therapeutic potential of natural GLP-1 is limited due to its rapid degradation by the enzyme dipeptidyl peptidase 4 (DPP-4), GLP-1 analogs have been developed that are DPP-4 resistant
Indications: FDA approved: Type II diabetes - monotherapy or combination therapy Can be combined as adjunct therapy with other hypoglycemics including metformin, thiazolidinediones, or insulin regimens (Dungan & DeSantis 2015) Because it does not work when your blood sugar is low, it is unlikely to produce dangerous levels of hypoglycemia has been observed in clinical trials (in contrast to GLP-1 incretin mimetics, such as exenatide, which produce moderate weight loss)
Truly revitalized and refreshed. I left feeling like a new person
Biomed Pharmacother 123:109776 Bakker K, van Houtum WH, Riley PC (2005) The International Diabetes Federation focuses on the diabetic foot
Proper storage and handling of Reta is crucial to maintain compound integrity and research results
